It provides a forum for WHO member states to collaborate in monitoring drug safety. Within the programme, individual case reports of suspected adverse drug reactions are collected.
Creador(es): World Health Organization - WHO, WHO Collaborating Centre for International Drug Monitoring / Uppsala Monitoring Centre - UMC.
Recursos añadido en:
28/11/2001
Idiomas disponibles:
Inglés
comments powered by Disqus